---
schema_version: "secwatch.filing_event.v1"
accession: "0000816956-25-000026"
form_type: "8-K"
ticker: "CNMD"
cik: "0000816956"
company_name: "CONMED Corp"
filed_at: "2025-07-30T23:59:59+00:00"
generated_at: "2026-05-17T23:21:35.402661+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CONMED Q2 adj EPS $1.15 beats; raises FY2025 revenue and adj EPS guidance

## Summary
- Q2 sales $342.3M (+3.1% YoY); GAAP EPS $0.69 (down from $0.96), adj EPS $1.15 (up from $0.98).
- Single-use products +6.6% to $297.8M; capital products -15.5% to $44.5M.
- FY revenue guidance raised to $1.356B-1.378B; adj EPS raised to $4.40-4.55 (prior $4.31-4.46).
- Company estimates ~$0.09 EPS headwind from tariffs in H2 2025.
- Operational optimization consulting fees $7.6M in Q2; exec transition costs $12.2M YTD.

## SEC filing metadata
- accession: 0000816956-25-000026
- form_type: 8-K
- ticker: CNMD
- cik: 0000816956
- company_name: CONMED Corp
- filed_at: 2025-07-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/816956/000081695625000026/0000816956-25-000026-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/816956/000081695625000026/cnmd-20250730.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000816956-25-000026
- JSON: https://secwatch.observer/filing/0000816956-25-000026.json
- Plain text: https://secwatch.observer/filing/0000816956-25-000026.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.